Hypogammaglobulinaemia

Immunology and Allergy Clinics of North America

Volumn 28, Issue 4, 2008, Pages 691-713

  Yong, Patrick F K ^a,b   Chee, Ronnie ^b   Grimbacher, Bodo ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Agammaglobulinaemia; Class switch recombination defects; Common variable immunodeficiency; Hypogammaglobulinaemia; Primary antibody deficiency; Primary immunodeficiency

Indexed keywords

ANTIBIOTIC AGENT; BRUTON TYROSINE KINASE; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN M;

ACTIVATION INDUCED CYTIDINE DEAMINASE DEFICIENCY; ANTIBIOTIC THERAPY; AUTOIMMUNE DISEASE; B CELL ACTIVATING FACTOR RECEPTOR DEFICIENCY; B LYMPHOCYTE; BTK GENE; CAMPYLOBACTER JEJUNI; CD19 DEFICIENCY; CHROMOSOME DELETION; CLINICAL FEATURE; COMMON VARIABLE IMMUNODEFICIENCY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DYSKERATOSIS CONGENITA; FOLLOW UP; GASTROINTESTINAL DISEASE; GENE; GENE MUTATION; GENETIC DISORDER; GENETICS; GIARDIA LAMBLIA; HUMAN; HUMORAL IMMUNE DEFICIENCY; IMMUNE DEFICIENCY; IMMUNOGLOBULIN A DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEFICIENCY; IMMUNOPATHOLOGY; IMMUNOTHERAPY; INDUCIBLE COSTIMULATOR DEFICIENCY; INFECTION; ISOLATED IGG SUBCLASS DEFICIENCY; KAPPA CHAIN DEFICIENCY; MSH5 GENE; MYELODYSPLASIA; PRIORITY JOURNAL; RECURRENT INFECTION; REVIEW; SALMONELLA; T LYMPHOCYTE; THYMOMA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME; URACIL DNA GLYCOSYLASE DEFICIENCY; X LINKED AGAMMAGLOBULINEMIA; X LINKED LYMPHOPROLIFERATIVE SYNDROME;

AGAMMAGLOBULINEMIA; ANIMALS; B-LYMPHOCYTES; GENES, RECESSIVE; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULINS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC TESTS; INFANT; INFANT, NEWBORN;

EID: 53649084683     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2008.06.003     Document Type: Review

References (166)

1. Conley M.E., Notarangelo L.D., and Etzioni A. Diagnostic criteria for primary immunodeficiencies: representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 93 3 (1999) 190-197
2. International Union of Immunological Societies. Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. Clin Exp Immunol 118 Suppl 1 (1999) 1-28
3. Chapel H., Geha R., and Rosen F. Primary immunodeficiency diseases: an update. Clin Exp Immunol 132 1 (2003) 9-15
4. Notarangelo L., Casanova J.L., Conley M.E., et al. Primary immunodeficiency diseases: an update from the International Union of Immunological SocietiesPrimary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005. J Allergy Clin Immunol 117 4 (2006) 883-896
5. Geha R.S., Notarangelo L.D., Casanova J.L., et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol 120 4 (2007) 776-794
6. Eades-Perner A.M., Gathmann B., Knerr V., et al. The European Internet-based patient and research database for primary immunodeficiencies: results 2004-06. Clin Exp Immunol 147 2 (2007) 306-312
7. Kirkpatrick P., and Riminton S. Primary immunodeficiency diseases in Australia and New Zealand. J Clin Immunol 27 5 (2007) 517-524
8. Bruton O.C. Agammaglobulinemia. Pediatrics 9 6 (1952) 722-728
9. Vetrie D., Vorechovsky I., Sideras P., et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 361 6409 (1993) 226-233
10. Tsukada S., Saffran D.C., Rawlings D.J., et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72 2 (1993) 279-290
11. Winkelstein J.A., Marino M.C., Lederman H.M., et al. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore) 85 4 (2006) 193-202
12. Matamoros F.N., Mila L.J., Espanol B.T., et al. Primary immunodeficiency syndrome in Spain: first report of the National Registry in children and adults. J Clin Immunol 17 4 (1997) 333-339
13. Stray-Pedersen A., Abrahamsen T.G., and Froland S.S. Primary immunodeficiency diseases in Norway. J Clin Immunol 20 6 (2000) 477-485
14. Rohrer J., Parolini O., Belmont J.W., et al. The genomic structure of human BTK, the defective gene in X-linked agammaglobulinemia. Immunogenetics 40 5 (1994) 319-324
15. Mano H., Ishikawa F., Nishida J., et al. A novel protein-tyrosine kinase, tec, is preferentially expressed in liver. Oncogene 5 12 (1990) 1781-1786
16. Genevier H.C., Hinshelwood S., Gaspar H.B., et al. Expression of Bruton's tyrosine kinase protein within the B cell lineage. Eur J Immunol 24 12 (1994) 3100-3105
17. Smith C.I., Baskin B., Humire-Greiff P., et al. Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells. J Immunol 152 2 (1994) 557-565
18. Aoki Y., Isselbacher K.J., and Pillai S. Bruton tyrosine kinase is tyrosine phosphorylated and activated in pre-B lymphocytes and receptor-ligated B cells. Proc Natl Acad Sci U S A 91 22 (1994) 10606-10609
19. Rawlings D.J., Scharenberg A.M., Park H., et al. Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases. Science 271 5250 (1996) 822-825
20. Bu J.Y., Shaw A.S., and Chan A.C. Analysis of the interaction of ZAP-70 and syk protein-tyrosine kinases with the T-cell antigen receptor by plasmon resonance. Proc Natl Acad Sci U S A 92 11 (1995) 5106-5110
21. Fu C., Turck C.W., Kurosaki T., et al. BLNK: a central linker protein in B cell activation. Immunity 9 1 (1998) 93-103
22. Humphries L.A., Dangelmaier C., Sommer K., et al. Tec kinases mediate sustained calcium influx via site-specific tyrosine phosphorylation of the phospholipase Cgamma Src homology 2-Src homology 3 linker. J Biol Chem 279 36 (2004) 37651-37661
23. Conley M.E., Broides A., Hernandez-Trujillo V., et al. Genetic analysis of patients with defects in early B-cell development. Immunol Rev 203 (2005) 216-234
24. Broides A., Yang W., and Conley M.E. Genotype/phenotype correlations in X-linked agammaglobulinemia. Clin Immunol 118 2-3 (2006) 195-200
25. Kornfeld S.J., Haire R.N., Strong S.J., et al. A novel mutation (Cys145→Stop) in Bruton's tyrosine kinase is associated with newly diagnosed X-linked agammaglobulinemia in a 51-year-old male. Mol Med 2 5 (1996) 619-623
26. Conley M.E., Fitch-Hilgenberg M.E., Cleveland J.L., et al. Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase. Hum Mol Genet 3 10 (1994) 1751-1756
27. Bykowsky M.J., Haire R.N., Ohta Y., et al. Discordant phenotype in siblings with X-linked agammaglobulinemia. Am J Hum Genet 58 3 (1996) 477-483
28. Morwood K., Bourne H., Gold M., et al. Phenotypic variability: clinical presentation between the 6th year and the 60th year in a family with X-linked agammaglobulinemia. J Allergy Clin Immunol 113 4 (2004) 783-785
29. Takada H., Kanegane H., Nomura A., et al. Female agammaglobulinemia due to the Bruton tyrosine kinase deficiency caused by extremely skewed X-chromosome inactivation. Blood 103 1 (2004) 185-187
30. Moin M., Aghamohammadi A., Farhoudi A., et al. X-linked agammaglobulinemia: a survey of 33 Iranian patients. Immunol Invest 33 1 (2004) 81-93
31. Plebani A., Soresina A., Rondelli R., et al. Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study. Clin Immunol 104 3 (2002) 221-230
32. Conley M.E., and Howard V. Clinical findings leading to the diagnosis of X-linked agammaglobulinemia. J Pediatr 141 4 (2002) 566-571
33. Alibrahim A., Lepore M., Lierl M., et al. Pneumocystis carinii pneumonia in an infant with X-linked agammaglobulinemia. J Allergy Clin Immunol 101 4 Pt 1 (1998) 552-553
34. Dittrich A.M., Schulze I., Magdorf K., et al. X-linked agammaglobulinaemia and Pneumocystis carinii pneumonia: an unusual coincidence?. Eur J Pediatr 162 6 (2003) 432-433
35. Misbah S.A., Spickett G.P., Ryba P.C., et al. Chronic enteroviral meningoencephalitis in agammaglobulinemia: case report and literature review. J Clin Immunol 12 4 (1992) 266-270
36. Wilfert C.M., Buckley R.H., Mohanakumar T., et al. Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia. N Engl J Med 296 26 (1977) 1485-1489
37. Halliday E., Winkelstein J., and Webster A.D. Enteroviral infections in primary immunodeficiency (PID): a survey of morbidity and mortality. J Infect 46 1 (2003) 1-8
38. Bardelas J.A., Winkelstein J.A., Seto D.S., et al. Fatal ECHO 24 infection in a patient with hypogammaglobulinemia: relationship to dermatomyositis-like syndrome. J Pediatr 90 3 (1977) 396-399
39. Franz A., Webster A.D., Furr P.M., et al. Mycoplasmal arthritis in patients with primary immunoglobulin deficiency: clinical features and outcome in 18 patients. Br J Rheumatol 36 6 (1997) 661-668
40. Echave-Sustaeta J.M., Villena V., Verdugo M., et al. X-linked agammaglobulinaemia and squamous lung cancer. Eur Respir J 17 3 (2001) 570-572
41. Lavilla P., Gil A., Rodriguez M.C., et al. X-linked agammaglobulinemia and gastric adenocarcinoma. Cancer 72 5 (1993) 1528-1531
42. Lederman H.M., and Winkelstein J.A. X-linked agammaglobulinemia: an analysis of 96 patients. Medicine (Baltimore) 64 3 (1985) 145-156
43. van Der Meer J.W., Weening R.S., Schellekens P.T., et al. Colorectal cancer in patients with X-linked agammaglobulinaemia. Lancet 341 8858 (1993) 1439-1440
44. Yong P.F., Grosse-Kreul D., Maher J., et al. Dermatofibrosarcoma protuberans in a patient with X-linked agammaglobulinaemia. J Clin Pathol 60 10 (2007) 1162-1164
45. Hermaszewski R.A., and Webster A.D. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med 86 1 (1993) 31-42
46. Lopez G.E., Porpiglia A.S., Hogan M.B., et al. Clinical and molecular analysis of patients with defects in micro heavy chain gene. J Clin Invest 110 7 (2002) 1029-1035
47. Yel L., Minegishi Y., Coustan-Smith E., et al. Mutations in the mu heavy-chain gene in patients with agammaglobulinemia. N Engl J Med 335 20 (1996) 1486-1493
48. Ferrari S., Lougaris V., Caraffi S., et al. Mutations of the Igbeta gene cause agammaglobulinemia in man. J Exp Med 204 9 (2007) 2047-2051
49. Dobbs A.K., Yang T., Farmer D., et al. Cutting edge: a hypomorphic mutation in Igbeta (CD79b) in a patient with immunodeficiency and a leaky defect in B cell development. J Immunol 179 4 (2007) 2055-2059
50. Wang Y., Kanegane H., Sanal O., et al. Novel Igalpha (CD79a) gene mutation in a Turkish patient with B cell-deficient agammaglobulinemia. Am J Med Genet 108 4 (2002) 333-336
51. Minegishi Y., Coustan-Smith E., Wang Y.H., et al. Mutations in the human lambda5/14.1 gene result in B cell deficiency and agammaglobulinemia. J Exp Med 187 1 (1998) 71-77
52. Minegishi Y., Coustan-Smith E., Rapalus L., et al. Mutations in Igalpha (CD79a) result in a complete block in B-cell development. J Clin Invest 104 8 (1999) 1115-1121
53. Minegishi Y., Rohrer J., Coustan-Smith E., et al. An essential role for BLNK in human B cell development. Science 286 5446 (1999) 1954-1957
54. Good R.A., and Varco R.L. A clinical and experimental study of agammaglobulinemia. J Lancet 75 6 (1955) 245-271
55. Tarr P.E., Sneller M.C., Mechanic L.J., et al. Infections in patients with immunodeficiency with thymoma (Good syndrome): report of 5 cases and review of the literature. Medicine (Baltimore) 80 2 (2001) 123-133
56. Watts R.G., and Kelly D.R. Fatal varicella infection in a child associated with thymoma and immunodeficiency (Good's syndrome). Med Pediatr Oncol 18 3 (1990) 246-251
57. Agarwal S., and Cunningham-Rundles C. Thymoma and immunodeficiency (Good syndrome): a report of 2 unusual cases and review of the literature. Ann Allergy Asthma Immunol 98 2 (2007) 185-190
58. Souadjian J.V., Enriquez P., Silverstein M.N., et al. The spectrum of diseases associated with thymoma: coincidence or syndrome?. Arch Intern Med 134 2 (1974) 374-379
59. Beck S., Slater D., and Harrington C.I. Fatal chronic cutaneous herpes simplex associated with thymoma and hypogammaglobulinaemia. Br J Dermatol 105 4 (1981) 471-474
60. Kelleher P., and Misbah S.A. What is Good's syndrome? Immunological abnormalities in patients with thymoma. J Clin Pathol 56 1 (2003) 12-16
61. Conley M.E. Early defects in B cell development. Curr Opin Allergy Clin Immunol 2 6 (2002) 517-522
62. Revy P., Busslinger M., Tashiro K., et al. A syndrome involving intrauterine growth retardation, microcephaly, cerebellar hypoplasia, B lymphocyte deficiency, and progressive pancytopenia. Pediatrics 105 3 (2000) E39
63. Srivannaboon K., Conley M.E., Coustan-Smith E., et al. Hypogammaglobulinemia and reduced numbers of B-cells in children with myelodysplastic syndrome. J Pediatr Hematol Oncol 23 2 (2001) 122-125
64. Janeway C., Apt L., and Gitlin D. Agammaglobulinemia. Trans Assoc Am Physicians 66 (1953) 200-202
65. Cunningham-Rundles C., and Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 92 1 (1999) 34-48
66. Quinti I., Soresina A., Spadaro G., et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol 27 3 (2007) 308-316
67. Hammarstrom L., Vorechovsky I., and Webster D. Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 120 2 (2000) 225-231
68. Vorechovsky I., Webster A.D., Plebani A., et al. Genetic linkage of IgA deficiency to the major histocompatibility complex: evidence for allele segregation distortion, parent-of-origin penetrance differences, and the role of anti-IgA antibodies in disease predisposition. Am J Hum Genet 64 4 (1999) 1096-1109
69. Espanol T., Catala M., Hernandez M., et al. Development of a common variable immunodeficiency in IgA-deficient patients. Clin Immunol Immunopathol 80 3 Pt 1 (1996) 333-335
70. Rotbart H.A., and Webster A.D. Treatment of potentially life-threatening enterovirus infections with pleconaril. Clin Infect Dis 32 2 (2001) 228-235
71. Stack E., Washington K., Avant G.R., et al. Cytomegalovirus enteritis in common variable immunodeficiency. South Med J 97 1 (2004) 96-101
72. Michel M., Chanet V., Galicier L., et al. Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature. Medicine (Baltimore) 83 4 (2004) 254-263
73. Davies C.W., Juniper M.C., Gray W., et al. Lymphoid interstitial pneumonitis associated with common variable hypogammaglobulinaemia treated with cyclosporin A. Thorax 55 1 (2000) 88-90
74. Bates C.A., Ellison M.C., Lynch D.A., et al. Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency. J Allergy Clin Immunol 114 2 (2004) 415-421
75. Morimoto Y., and Routes J.M. Granulomatous disease in common variable immunodeficiency. Curr Allergy Asthma Rep 5 5 (2005) 370-375
76. Mechanic L.J., Dikman S., and Cunningham-Rundles C. Granulomatous disease in common variable immunodeficiency. Ann Intern Med 127 8 Pt 1 (1997) 613-617
77. Kinlen L.J., Webster A.D., Bird A.G., et al. Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet 1 8423 (1985) 263-266
78. Cambronero R., Sewell W.A., North M.E., et al. Up-regulation of IL-12 in monocytes: a fundamental defect in common variable immunodeficiency. J Immunol 164 1 (2000) 488-494
79. Bayry J., Lacroix-Desmazes S., Kazatchkine M.D., et al. Common variable immunodeficiency is associated with defective functions of dendritic cells. Blood 104 8 (2004) 2441-2443
80. Cunningham-Rundles C., and Radigan L. Deficient IL-12 and dendritic cell function in common variable immune deficiency. Clin Immunol 115 2 (2005) 147-153
81. Scott-Taylor T.H., Green M.R., Eren E., et al. Monocyte derived dendritic cell responses in common variable immunodeficiency. Clin Exp Immunol 138 3 (2004) 484-490
82. Viallard J.F., Camou F., Andre M., et al. Altered dendritic cell distribution in patients with common variable immunodeficiency. Arthritis Res Ther 7 5 (2005) R1052-R1055
83. Cunningham-Rundles C., Radigan L., Knight A.K., et al. TLR9 activation is defective in common variable immune deficiency. J Immunol 176 3 (2006) 1978-1987
84. Sneller M.C., and Strober W. Abnormalities of lymphokine gene expression in patients with common variable immunodeficiency. J Immunol 144 10 (1990) 3762-3769
85. Kondratenko I., Amlot P.L., Webster A.D., et al. Lack of specific antibody response in common variable immunodeficiency (CVID) associated with failure in production of antigen-specific memory T cells. MRC Immunodeficiency Group. Clin Exp Immunol 108 1 (1997) 9-13
86. Farrington M., Grosmaire L.S., Nonoyama S., et al. CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc Natl Acad Sci U S A 91 3 (1994) 1099-1103
87. Di R.M., Serrano D., Zhou Z., et al. Enhanced T cell apoptosis in common variable immunodeficiency: negative role of the fas/fasligand system and of the Bcl-2 family proteins and possible role of TNF-RS. Clin Exp Immunol 125 1 (2001) 117-122
88. Pozzi N., Gaetaniello L., Martire B., et al. Defective surface expression of attractin on T cells in patients with common variable immunodeficiency (CVID). Clin Exp Immunol 123 1 (2001) 99-104
89. Holm A.M., Aukrust P., Damas J.K., et al. Abnormal interleukin-7 function in common variable immunodeficiency. Blood 105 7 (2005) 2887-2890
90. Boncristiano M., Majolini M.B., D'Elios M.M., et al. Defective recruitment and activation of ZAP-70 in common variable immunodeficiency patients with T cell defects. Eur J Immunol 30 9 (2000) 2632-2638
91. Paccani S.R., Boncristiano M., Patrussi L., et al. Defective vav expression and impaired F-actin reorganization in a subset of patients with common variable immunodeficiency characterized by T-cell defects. Blood 106 2 (2005) 626-634
92. Bryant A., Calver N.C., Toubi E., et al. Classification of patients with common variable immunodeficiency by B cell secretion of IgM and IgG in response to anti-IgM and interleukin-2. Clin Immunol Immunopathol 56 2 (1990) 239-248
93. Warnatz K., Denz A., Drager R., et al. Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 99 5 (2002) 1544-1551
94. Piqueras B., Lavenu-Bombled C., Galicier L., et al. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol 23 5 (2003) 385-400
95. Wehr C., Kivioja T., Schmitt C., et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 111 1 (2008) 77-85
96. Giovannetti A., Pierdominici M., Mazzetta F., et al. Unravelling the complexity of T cell abnormalities in common variable immunodeficiency. J Immunol 178 6 (2007) 3932-3943
97. Yong P.F., Workman S., Wahid F., et al. Selective deficits in blood dendritic cell subsets in common variable immunodeficiency and X-linked agammaglobulinaemia but not specific polysaccharide antibody deficiency. Clin Immunol 127 1 (2008) 34-42
98. Grimbacher B., Hutloff A., Schlesier M., et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 4 3 (2003) 261-268
99. Salzer U., Chapel H.M., Webster A.D., et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 37 8 (2005) 820-828
100. Castigli E., Wilson S.A., Garibyan L., et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 37 8 (2005) 829-834
101. Warnatz K, Salzer U, Gutenberger S. Finally found: human BAFF-R deficiency causes CVID. XIth Meeting of the European Society for Immunodeficiencies. Versailles (France), October 21-24, 2004.
102. van Zelm M.C., Reisli I., van der B.M., et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med 354 18 (2006) 1901-1912
103. Kanegane H., Agematsu K., Futatani T., et al. Novel mutations in a Japanese patient with CD19 deficiency. Genes Immun 8 8 (2007) 663-670
104. Sekine H., Ferreira R.C., Pan-Hammarstrom Q., et al. Role for Msh5 in the regulation of Ig class switch recombination. Proc Natl Acad Sci U S A 104 17 (2007) 7193-7198
105. Carreno B.M., and Collins M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 20 (2002) 29-53
106. Carter R.H., and Fearon D.T. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256 5053 (1992) 105-107
107. Salzer U., Maul-Pavicic A., Cunningham-Rundles C., et al. ICOS deficiency in patients with common variable immunodeficiency. Clin Immunol 113 3 (2004) 234-240
108. Schneider P. The role of APRIL and BAFF in lymphocyte activation. Curr Opin Immunol 17 3 (2005) 282-289
109. Bacchelli C., Buckridge S., Thrasher A.J., et al. Translational mini-review series on immunodeficiency: molecular defects in common variable immunodeficiency. Clin Exp Immunol 149 3 (2007) 401-409
110. Zhang L., Radigan L., Salzer U., et al. Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes. J Allergy Clin Immunol 120 5 (2007) 1178-1185
111. Pan-Hammarstrom Q., Salzer U., Du L., et al. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet 39 4 (2007) 429-430
112. Castigli E., Wilson S., Garibyan L., et al. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet 39 4 (2007) 430-431
113. Fearon D.T., and Carroll M.C. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu Rev Immunol 18 (2000) 393-422
114. Purtilo D.T., Cassel C., and Yang J.P. Letter: fatal infectious mononucleosis in familial lymphohistiocytosis. N Engl J Med 291 14 (1974) 736
115. Seemayer T.A., Gross T.G., Egeler R.M., et al. X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr Res 38 4 (1995) 471-478
116. Coffey A.J., Brooksbank R.A., Brandau O., et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet 20 2 (1998) 129-135
117. Sayos J., Wu C., Morra M., et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 395 6701 (1998) 462-469
118. Rigaud S., Fondaneche M.C., Lambert N., et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 444 7115 (2006) 110-114
119. Eastwood D., Gilmour K.C., Nistala K., et al. Prevalence of SAP gene defects in male patients diagnosed with common variable immunodeficiency. Clin Exp Immunol 137 3 (2004) 584-588
120. Notarangelo L.D., Duse M., and Ugazio A.G. Immunodeficiency with hyper-IgM (HIM). Immunodefic Rev 3 2 (1992) 101-121
121. Winkelstein J.A., Marino M.C., Ochs H., et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore) 82 6 (2003) 373-384
122. Aruffo A., Farrington M., Hollenbaugh D., et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72 2 (1993) 291-300
123. DiSanto J.P., Bonnefoy J.Y., Gauchat J.F., et al. CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM. Nature 361 6412 (1993) 541-543
124. Ferrari S., Giliani S., Insalaco A., et al. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci U S A 98 22 (2001) 12614-12619
125. Doffinger R., Smahi A., Bessia C., et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet 27 3 (2001) 277-285
126. Jain A., Ma C.A., Liu S., et al. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol 2 3 (2001) 223-228
127. Revy P., Muto T., Levy Y., et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102 5 (2000) 565-575
128. Durandy A., Revy P., Imai K., et al. Hyper-immunoglobulin M syndromes caused by intrinsic B-lymphocyte defects. Immunol Rev 203 (2005) 67-79
129. Quartier P., Bustamante J., Sanal O., et al. Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to activation-induced cytidine deaminase deficiency. Clin Immunol 110 1 (2004) 22-29
130. Minegishi Y., Lavoie A., Cunningham-Rundles C., et al. Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome. Clin Immunol 97 3 (2000) 203-210
131. Zhu Y., Nonoyama S., Morio T., et al. Type two hyper-IgM syndrome caused by mutation in activation-induced cytidine deaminase. J Med Dent Sci 50 1 (2003) 41-46
132. Durandy A., Peron S., Taubenheim N., et al. Activation-induced cytidine deaminase: structure-function relationship as based on the study of mutants. Hum Mutat 27 12 (2006) 1185-1191
133. Ta V.T., Nagaoka H., Catalan N., et al. AID mutant analyses indicate requirement for class-switch-specific cofactors. Nat Immunol 4 9 (2003) 843-848
134. Barreto V., Reina-San-Martin B., Ramiro A.R., et al. C-terminal deletion of AID uncouples class switch recombination from somatic hypermutation and gene conversion. Mol Cell 12 2 (2003) 501-508
135. Kasahara Y., Kaneko H., Fukao T., et al. Hyper-IgM syndrome with putative dominant negative mutation in activation-induced cytidine deaminase. J Allergy Clin Immunol 112 4 (2003) 755-760
136. Imai K., Slupphaug G., Lee W.I., et al. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat Immunol 4 10 (2003) 1023-1028
137. Di N.J., and Neuberger M.S. Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase. Nature 419 6902 (2002) 43-48
138. Imai K., Catalan N., Plebani A., et al. Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination. J Clin Invest 112 1 (2003) 136-142
139. Brusco A., Cariota U., Bottaro A., et al. Variability of the immunoglobulin heavy chain constant region locus: a population study. Hum Genet 95 3 (1995) 319-326
140. Zegers B.J., Maertzdorf W.J., Van L.E., et al. Kappa-chain deficiency: an immunoglobulin disorder. N Engl J Med 294 19 (1976) 1026-1030
141. Stavnezer-Nordgren J., Kekish O., and Zegers B.J. Molecular defects in a human immunoglobulin kappa chain deficiency. Science 230 4724 (1985) 458-461
142. Schur P.H., Borel H., Gelfand E.W., et al. Selective gamma-g globulin deficiencies in patients with recurrent pyogenic infections. N Engl J Med 283 12 (1970) 631-634
143. Jefferis R., and Kumararatne D.S. Selective IgG subclass deficiency: quantification and clinical relevance. Clin Exp Immunol 81 3 (1990) 357-367
144. Maguire G.A., Kumararatne D.S., and Joyce H.J. Are there any clinical indications for measuring IgG subclasses?. Ann Clin Biochem 39 Pt 4 (2002) 374-377
145. Bonilla F.A., Bernstein I.L., Khan D.A., et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol 94 5 Suppl 1 (2005) S1-S63
146. Buckley R.H. Immunoglobulin G subclass deficiency: fact or fancy?. Curr Allergy Asthma Rep 2 5 (2002) 356-360
147. Clark J.A., Callicoat P.A., Brenner N.A., et al. Selective IgA deficiency in blood donors. Am J Clin Pathol 80 2 (1983) 210-213
148. Litzman J., Sevcikova I., Stikarovska D., et al. IgA deficiency in Czech healthy individuals and selected patient groups. Int Arch Allergy Immunol 123 2 (2000) 177-180
149. Ulfarsson J., Gudmundsson S., Birgisdottir B., et al. Selective serum IgA deficiency in Icelanders: frequency, family studies and Ig levels. Acta Med Scand 211 6 (1982) 481-487
150. Edwards E., Razvi S., and Cunningham-Rundles C. IgA deficiency: clinical correlates and responses to pneumococcal vaccine. Clin Immunol 111 1 (2004) 93-97
151. Hanson L.A., Bjorkander J., Carlsson B., et al. The heterogeneity of IgA deficiency. J Clin Immunol 8 3 (1988) 159-162
152. Alaswad B., and Brosnan P. The association of celiac disease, diabetes mellitus type 1, hypothyroidism, chronic liver disease, and selective IgA deficiency. Clin Pediatr (Phila) 39 4 (2000) 229-231
153. Cunningham-Rundles C., Pudifin D.J., Armstrong D., et al. Selective IgA deficiency and neoplasia. Vox Sang 38 2 (1980) 61-67
154. Mellemkjaer L., Hammarstrom L., Andersen V., et al. Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study. Clin Exp Immunol 130 3 (2002) 495-500
155. Bossuyt X., Moens L., Van H.E., et al. Coexistence of (partial) immune defects and risk of recurrent respiratory infections. Clin Chem 53 1 (2007) 124-130
156. Saxon A., Kobayashi R.H., Stevens R.H., et al. In vitro analysis of humoral immunity in antibody deficiency with normal immunoglobulins. Clin Immunol Immunopathol 17 2 (1980) 235-244
157. Cheng Y.K., Decker P.A., O'Byrne M.M., et al. Clinical and laboratory characteristics of 75 patients with specific polysaccharide antibody deficiency syndrome. Ann Allergy Asthma Immunol 97 3 (2006) 306-311
158. Sorensen R.U., Leiva L.E., Javier III F.C., et al. Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations. J Allergy Clin Immunol 102 2 (1998) 215-221
159. Kirkpatrick C.H. Specific polysaccharide antibody deficiency. Ann Allergy Asthma Immunol 97 3 (2006) 271
160. Gitlin D., and Janeway C. Agammaglobulinemia, congenital, acquired and transient forms. Prog Hematol 1 (1956) 318-329
161. Whelan M.A., Hwan W.H., Beausoleil J., et al. Infants presenting with recurrent infections and low immunoglobulins: characteristics and analysis of normalization. J Clin Immunol 26 1 (2006) 7-11
162. Dalal I., Reid B., Nisbet-Brown E., et al. The outcome of patients with hypogammaglobulinemia in infancy and early childhood. J Pediatr 133 1 (1998) 144-146
163. Walker A.M., Kemp A.S., Hill D.J., et al. Features of transient hypogammaglobulinaemia in infants screened for immunological abnormalities. Arch Dis Child 70 3 (1994) 183-186
164. Kidon M.I., Handzel Z.T., Schwartz R., et al. Symptomatic hypogammaglobulinemia in infancy and childhood - clinical outcome and in vitro immune responses. BMC Fam Pract 5 (2004) 23
165. Kilic S.S., Tezcan I., Sanal O., et al. Transient hypogammaglobulinemia of infancy: clinical and immunologic features of 40 new cases. Pediatr Int 42 6 (2000) 647-650
166. Kosnik E.F., Johnson J.P., Rennels M.B., et al. Streptococcal sepsis presenting as acute abdomen in a child with transient hypogammaglobulinemia of infancy. J Pediatr Surg 21 11 (1986) 975-976